Exscientia PLC
NASDAQ:EXAI

Watchlist Manager
Exscientia PLC Logo
Exscientia PLC
NASDAQ:EXAI
Watchlist
Price: 5.54 USD -1.25% Market Closed
Market Cap: 716.1m USD
Have any thoughts about
Exscientia PLC?
Write Note

Exscientia PLC
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Exscientia PLC
Research & Development Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Exscientia PLC
NASDAQ:EXAI
Research & Development
-ÂŁ117m
CAGR 3-Years
-105%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Research & Development
-$124.4m
CAGR 3-Years
-137%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Research & Development
-$122.3m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Research & Development
-$167.9m
CAGR 3-Years
-59%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Research & Development
-ÂŁ163.5m
CAGR 3-Years
-30%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Exscientia PLC's Research & Development?
Research & Development
-117m GBP

Based on the financial report for Dec 31, 2023, Exscientia PLC's Research & Development amounts to -117m GBP.

What is Exscientia PLC's Research & Development growth rate?
Research & Development CAGR 3Y
-105%

Over the last year, the Research & Development growth was 22%. The average annual Research & Development growth rates for Exscientia PLC have been -105% over the past three years .

Back to Top